[HTML][HTML] Clinical-pathologic challenges in the classification of pulmonary neuroendocrine neoplasms and targets on the horizon for future clinical practice

JL Derks, N Rijnsburger, BCM Hermans… - Journal of Thoracic …, 2021 - Elsevier
Diagnosing a pulmonary neuroendocrine neoplasm (NEN) may be difficult, challenging
clinical decision making. In this review key clinical and pathological issues and informative …

[HTML][HTML] Molecular pathology of well-differentiated pulmonary and thymic neuroendocrine tumors: what do pathologists need to know?

M Volante, O Mete, G Pelosi, AC Roden, EJM Speel… - Endocrine …, 2021 - Springer
Thoracic (pulmonary and thymic) neuroendocrine tumors are well-differentiated epithelial
neuroendocrine neoplasms that are classified into typical and atypical carcinoid tumors …

Pulmonary neuroendocrine neoplasms with well differentiated morphology and high proliferative activity: illustrated by a case series and review of the literature

BCM Hermans, JL Derks, L Moonen, CHJ Habraken… - Lung Cancer, 2020 - Elsevier
Abstract Objectives Pulmonary neuroendocrine neoplasms (NENs) are subdivided in
carcinoids and neuroendocrine carcinomas (small cell lung carcinoma and large cell …

[HTML][HTML] Prognostic significance of laterality in lung neuroendocrine tumors

A La Salvia, I Persano, A Siciliani, M Verrico, M Bassi… - Endocrine, 2022 - Springer
Purpose: Well-differentiated lung neuroendocrine tumors (Lu-NET) are classified as typical
(TC) and atypical (AC) carcinoids, based on mitotic counts and necrosis. However …

[HTML][HTML] Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and …

Y Zhang, W Wang, Q Hu, Z Liang, P Zhou, Y Tang… - BMC cancer, 2022 - Springer
Background Pulmonary neuroendocrine neoplasms can be divided into typical carcinoid,
atypical carcinoid, large cell neuroendocrine carcinoma, and small cell (lung) carcinoma …

Neuroendocrine tumor G3 of bronchopulmonary origin and its classification

A Kasajima, G Klöppel - Pathology International, 2022 - Wiley Online Library
Neuroendocrine tumors (NET) with high proliferative activity (Ki‐67 index> 20% and/or
mitotic counts> 2 mm2) are defined as NET G3 in the 2019 World Health Organization …

[HTML][HTML] Beyond traditional morphological characterization of lung neuroendocrine neoplasms: In silico study of next-generation sequencing mutations analysis across …

G Centonze, D Biganzoli, N Prinzi, S Pusceddu… - Cancers, 2020 - mdpi.com
Simple Summary Lung neuroendocrine neoplasms (LNENs) classes, as proposed by the
World Health Organization 2015, do not provide properly prognostic and therapeutic …

[HTML][HTML] Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker …

R Blázquez-Encinas, V García-Vioque… - Journal of Translational …, 2023 - Springer
Abstract Background Lung neuroendocrine neoplasms (LungNENs) comprise a
heterogeneous group of tumors ranging from indolent lesions with good prognosis to highly …

Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas

H Wang, L Yan, Y Zhu, W Sun, X Yang, X Liu, K Chi… - Human Pathology, 2023 - Elsevier
Molecular research on large-cell neuroendocrine carcinoma (LCNEC) and small-cell lung
cancer (SCLC) has progressed significantly. However, there are still fewer molecular …

All Together Now: Standardization of Nomenclature for Neuroendocrine Neoplasms across Multiple Organs

P Jafari, AN Husain, N Setia - Surgical Pathology Clinics, 2023 - surgpath.theclinics.com
Neuroendocrine neoplasms (NENs) span virtually all organ systems and exhibit a broad
spectrum of behavior, from indolent to highly aggressive. Historically, nomenclature and …